Artha Sootra - Company Dashboard

Governance Classic Home

Lyka Labs LtdPharmaceuticalsINE933A01014Consolidated₹76.00+1.00 (+1.33%)

Valuation

Market Cap₹269.71 Cr

TTM PE-60.94x

Forward PE-47.23x

PEG1.19

Book Value₹26.83

P/B2.82x

TTM EPS₹-1.24

Fwd EPS₹-1.60

TTM Revenue₹145.27 Cr

TTM PAT₹-4.90 Cr

TTM EBITDA₹3.27 Cr

TTM EBIT₹-4.99 Cr

Last Qtr PAT₹1.27 Cr

Last Qtr EBITDA₹3.52 Cr

Last Qtr EBIT₹1.47 Cr

Profitability

ROE-5.12%

ROCE-1.44%

TTM NPM-3.37%

TTM EBITDA %2.25%

Curr OPM2.83%

Last OPM4.80%

Curr NPM—

Last NPM—

Curr EPS₹0.36

Last EPS₹0.57

Balance sheet

Equity₹36.15 Cr

Reserve₹59.59 Cr

Total Debt₹44.31 Cr

D/E0.46x

Interest %80.31%

Curr Interest₹1.02 Cr

Price / range

Close₹75.57

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D0.00%

1W-3.48%

1M-7.86%

3M+15.15%

6M+23.10%

1Y-20.38%

2Y-48.49%

3Y-30.32%

5Y-28.54%

Diwali-2.07%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	44.20+34.1%	42.31	28.03	30.73	32.97	120.91
Other Income	0.59	0.42	0.51	1.26	1.22	3.97
Total Income	44.79+31.0%	42.73	28.54	31.99	34.19	124.88
Interest	1.02	1.01	0.87	0.82	0.79	3.33
Expenditure	-43.67-12.0%	-40.73	-35.43	-31.71	-38.98	-135.10
PBDT	0	0	0	0	0	0
EBITDA	3.60+214.3%	4.60	-4.49	1.92	-3.15	-2.40
Depreciation	-2.05	-2.01	-2.04	-2.08	-2.07	-8.46
EBIT	1.55+129.7%	2.59	-6.53	-0.16	-5.22	-10.86
PBT	1.12+123.3%	1.99	-29.90	0.28	-4.80	-33.24
Tax	0.20	0.11	0.13	0	1.17	0.95
Equity	36.15	36.15	35.69	0	0	35.69
OPM	2.50	4.66	-104.77	0.90	-14.55	-26.61
Net Profit	1.32+136.4%	2.10	-29.77	0.28	-3.63	-32.29
NPM	2.95	4.91	-104.31	0.91	-11.00	-25.86
EPS	0.36+135.3%	0.58	-8.50	0.08	-1.02	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	120.91-10.2%	134.70+26.6%	106.40+32.0%	80.59-51.0%	164.35+164.0%	62.26
Other Income	3.97	2.34	1.65	3.45	2.72	2.21
Total Income	124.88-8.9%	137.04+26.8%	108.04+28.6%	84.04-49.7%	167.07+159.1%	64.47
Expenditure	-135.10-7.6%	-125.57-15.3%	-108.92-20.9%	-90.08+11.8%	-102.16-25.4%	-81.44
Interest	-3.33	-2.30	-4.80	-11.57	-19.92	-25.55
PBDT	0	0	0	0	0	0
EBITDA	-2.40-113.4%	17.88+22.7%	14.57-6.6%	15.60-84.0%	97.50+576.1%	14.42
Depreciation	-8.46	-6.45	-12.29	-13.52	-15.39	-8.05
EBIT	-10.86-195.0%	11.43+401.3%	2.28+9.6%	2.08-97.5%	82.11+1189.0%	6.37
PBT	-33.24-389.8%	11.47+1333.3%	-0.93+93.0%	-13.21-121.9%	60.24+427.4%	-18.40
Tax	0.95	-3.25	-1.34	-0.08	-20.34	3.94
Equity	35.69	35.69	0	0	0	0
OPM (%)	-26.61	8.37	-1.00	-16.00	36.00	-29.00
Net Profit	-32.29-492.3%	8.23+462.6%	-2.27+82.9%	-13.29-133.3%	39.90+375.9%	-14.46
NPM (%)	-25.86	6.00	-2.00	-16.00	24.00	-22.00
EPS (Rs)	0-100.0%	2.28+416.7%	-0.72+84.5%	-4.65-133.5%	13.87+373.0%	-5.08
CEPS	0	2.28	-0.72	-4.65	13.87	-5.08

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	44.20+20.6%	42.31	28.03	30.73	36.66	128.45
Other Income	0.62	0.42	0.61	1.16	1.09	3.50
Total Income	44.82+18.7%	42.73	28.64	31.89	37.75	131.94
Interest	1.02	1.01	0.70	0.82	0.79	3.33
Expenditure	-43.75-3.8%	-40.78	-37.23	-32.05	-42.14	-143.72
PBDT	0	0	0	0	0	0
EBITDA	3.52+238.6%	4.55	-6.46	1.66	-2.54	-3.49
Depreciation	-2.05	-2.01	-2.04	-2.16	-2.15	-8.46
EBIT	1.47+131.3%	2.54	-8.50	-0.50	-4.69	-11.95
PBT	1.07	1.95	-8.59	0	0	-11.78
Tax	0.20	0.10	0.52	0.01	1.17	1.34
Equity	36.15	36.15	35.69	0	0	35.69
OPM	2.39	4.56	-29.99	0.00	0.00	-8.93
Net Profit	1.27+139.6%	2.05	-8.07	-0.15	-3.21	-10.44
NPM	2.83	4.80	-28.18	-0.47	-8.51	-7.91
EPS	0.36+138.3%	0.57	-2.13	0	-0.94	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	128.44-7.3%	138.50+24.5%	111.20+19.5%	93.07-52.0%	194.09+125.0%	86.25
Other Income	3.50	2.23	1.46	3.40	2.09	1.56
Total Income	131.94-6.2%	140.73+24.9%	112.65+16.8%	96.47-50.8%	196.18+123.4%	87.81
Expenditure	-143.72-10.9%	-129.60-14.5%	-113.17-10.7%	-102.25+21.6%	-130.41-29.3%	-100.83
Interest	-3.33	-2.27	-4.89	-11.87	-20.13	-25.94
PBDT	0	0	0	0	0	0
EBITDA	-3.49-119.5%	17.94+14.1%	15.72-6.7%	16.84-83.4%	101.16+414.0%	19.68
Depreciation	-8.46	-6.77	-12.80	-14.15	-17.35	-8.32
EBIT	-11.95-207.0%	11.17+282.5%	2.92+8.6%	2.69-96.8%	83.81+637.8%	11.36
PBT	-11.78-205.9%	11.12+1295.7%	-0.93+92.9%	-13.17-122.2%	59.25+519.0%	-14.14
Tax	1.34	-3.19	-1.69	0.02	-20.80	4.05
Equity	35.69	35.69	0	0	0	0
OPM (%)	-8.93	7.91	-0.83	-13.65	30.20	-16.11
Net Profit	-10.44-231.7%	7.93+402.7%	-2.62+80.1%	-13.15-133.7%	39+437.4%	-11.56
NPM (%)	-7.91	5.64	-2.33	-13.63	19.88	-13.16
EPS (Rs)	0-100.0%	2.22+381.0%	-0.79+82.9%	-4.63-134.1%	13.57+433.4%	-4.07
CEPS	0	2.22	-0.79	-4.63	13.57	-4.07

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split